Form 4: Twist Bioscience CEO Emily Leproust Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Emily Leproust, CEO of Twist Bioscience, sold 1,732 shares of common stock on June 20, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.
Summary
- On June 20, 2024, Emily M. Leproust, CEO of Twist Bioscience, sold 1,732 shares of Twist Bioscience Corp (TWST) common stock.
- The sale was executed at a price of $49.41 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
- Following the transaction, Leproust directly owns 505,846 shares of Twist Bioscience common stock.
- Leproust also holds various employee stock options with exercise prices ranging from $5.95 to $67.85 and expiration dates between 2025 and 2030.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction (sale of shares to cover taxes) by the CEO. It's neutral in nature and doesn't indicate any significant positive or negative sentiment regarding the company's prospects.
Industry Context
Sales of shares to cover tax obligations are a routine part of executive compensation and are not necessarily indicative of a change in the executive's confidence in the company.
Comparison to Industry Standards
- Executive stock sales to cover tax obligations are common across publicly traded companies, including those in the biotechnology sector like Illumina (ILMN) and Thermo Fisher Scientific (TMO).
- The number of shares sold and the timing often depend on the company's equity compensation plans and individual tax situations.
- These transactions are generally viewed as standard practice and are not typically interpreted as a negative signal unless accompanied by other concerning news.
Stakeholder Impact
- The sale of shares by the CEO could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect.
- The transaction does not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 12/19/2022 | Performance stock options vested and became exercisable. |
| 06/20/2024 | Emily Leproust sold 1,732 shares of TWST stock. |
| 06/24/2024 | Date of Form 4 filing. |
| 08/31/2030 | Expiration date of employee stock options with an exercise price of $67.85. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.